Rebalix
Amundi · sheet of 10 September 2026
Amundi · sheet of 10 September 2026ETF sheet · official issuer and register data
Amundi MSCI EMU High Dividend UCITS ETF Acc
CD8 · FR0010717090 · class UCITS ETF Acc · EUR · domicile France
Equity · Eurozone · DividendSFDR art. 6
Index tracked: MSCI EMU High Dividend Yield Net Total Return Local Index
- TER
- 0.30%+ trans. 0.09%
- Fund size
- 388 m EUR
- Tracking difference
- +0.12%3-year avg
- 🇮🇹 tax rate
- —white list not published
- Replication
- Physical
- Income
- Accumulating
Launch 26 Feb 2009 · costs from the KID as of 2 Sept 2026 · 85 securities held · 9 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 4 Aug 2026
By subscribing to Amundi MSCI EMU High Dividend UCITS ETF (the "Fund"), you are investing in a passively managed UCITS whose objective is to replicate as closely as possible the performance of the MSCI EMU High Dividend Yield strategy index (the "Benchmark"), regardless of whether it experiences a positive or negative development. The maximum tracking error objective between the growth of the net asset value of the Fund and that of the Index is indicated in the Fund's prospectus. The Fund's Benchmark, net dividends reinvested (dividends, net of tax, paid…
Performance since series start (in euro) — base 100
10 Jul 2017 → 8 Sept 2026 · dividends reinvested where declared by the issuer
Returns in euro
| 1 year | +22.7% |
| 3 years | +48.0% |
| 5 years | +57.1% |
| 10 years | series too young |
| Since series start | +102.6% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 9.87% | 11.13% | 13.15% |
| Max drawdown | −6.25% | −14.64% | −20.84% |
| Sharpe | 1.87 | 0.91 | 0.56 |
| Sortino | 2.76 | 1.24 | 0.78 |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · CD8 · FR00107170901
RebalixCD8 · FR0010717090 · sheet of 10 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years · from issuer-declared series
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +20.87% | +20.82% | +0.05% |
| 2024 | +3.61% | +3.46% | +0.15% |
| 2023 | +16.71% | +16.54% | +0.17% |
| 2022 | −6.69% | −6.74% | +0.05% |
| 2021 | +16.40% | +16.43% | −0.03% |
Holdings
Portfolio as declared by the issuer · 1 Sept 2026 · 85 securities · top-10 weight = 43.6%
| Top holdings | Weight |
|---|---|
| 5.0% | |
| 4.9% | |
| 4.9% | |
| 4.5% | |
| 4.4% | |
| 4.3% | |
| 4.1% | |
| 4.0% | |
| 3.9% | |
| 3.6% |
Countries (% of fund)
Sectors (% of fund)
Listing venues
ESMA register (FIRDS) and official exchange lists
— · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange
CD8 · Euronext Paris
CD8GR · Xetra (Deutsche Börse)
+ 24 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
The live sheet, always up to date
rebalix.com/en/etf/FR0010717090
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/FR0010717090
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · CD8 · FR00107170902